Advice
following an abbreviated submission:
insulin lispro (Humalog® Mix25 KwikPen) and insulin lispro (Humalog® Mix50 KwikPen) are accepted for use within NHS Scotland for the treatment of patients with diabetes mellitus who require insulin for maintenance of normal glucose homeostasis, for whom treatment with this biphasic insulin analogue is appropriate.
Download detailed advice30KB (PDF)
Medicine details
- Medicine name:
- insulin lispro (Humalog Mix25, Mix50 KwikPen)
- SMC ID:
- 509/08
- Indication:
- for patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
- Pharmaceutical company
- MSD
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 13 October 2008